Advaferon (interferon alfacon-1) / Astellas, Sanofi - LARVOL DELTA

Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer. (PubMed, Front Oncol) - "As a result of this framework, we discovered both previously associated and novel drug candidates, including interferon alfacon-1, pimecrolimus, and hyaluronan specifically for HPV16 and HPV18 subtypes, respectively. Consequently, with this study, we have provided valuable data for further experimental and clinical efforts and presented a novel bioinformatics framework that can be applied to any infectious disease."

Journal • Cervical Cancer • Infectious Disease • Oncology • Solid Tumor

Pathway Analysis of Patients with Severe Acute Respiratory Syndrome. (PubMed, Drug Res (Stuttg)) - "An enhanced understanding of the pathways and molecular targets of SARS-CoV-1 in humans will contribute to current and future drug repurposing strategies, which are an essential tool to combat rapidly emerging health threats."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases